Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Ohr Pharmceutial (OHRP)

0.63 -0.02 (-3.08%)

10/20/2017  4:00pm

Open:

0.66

Pre. Close:

0.65

High:

0.66

Low:

0.61

Volume:

199,629

Market Cap:

35.41M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.67 - 0.68

0.68 - 0.69

Low:

0.59 - 0.6

0.6 - 0.61

Close:

0.62 - 0.64

0.64 - 0.65

Technical analysis  (as of: 2017-10-20 4:38:46 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.84     One year: 0.91

Support:

Support1: 0.61    Support2: 0.51

Resistance:

Resistance1: 0.72    Resistance2: 0.78

Pivot:

0.68

Moving Averages:

MA(5): 0.65     MA(20): 0.69

MA(100): 0.67     MA(250): 1.14

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 12.59     %D(3): 8.15

RSI:

RSI(14): 31.50

52-Week:

High: 3.78  Low: 0.56  Change(%): -82.3

Average Vol(K):

3-Month: 22207  10-Days 13560

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
OHRP has closed above bottom band by 1.8%. Bollinger Bands are 12.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 28 Jun 2011 08:04:06 GMT
0.63

Tue, 01 Jul 2014 14:12:29 GMT
The Ugly Truth Behind Ohr Pharma

Sat, 21 Oct 2017 22:30:00 GMT
Ohr Pharmaceuticals, Inc. (OHRP) Downgraded by Zacks Investment Research to “Hold”

Fri, 05 Feb 2016 13:42:56 GMT
Phase III Drugs: Teetering Between Success And Failure

Fri, 27 Mar 2015 17:25:26 GMT
Five Lessons From Ohr Pharma

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

Shares Float (M)

51.53

% Held by Insiders

4.89

% Held by Institutions

11.35

Shares Short (K)

1010

Shares Short Prior Month (K)

1030

Stock Financials

EPS

-0.650

EPS Est. Current Year

-0.950

EPS Est. Next Year

-1.550

EPS Est. Next Quarter

-0.080

Forward EPS

-0.679

Book Value (p.s.)

0.500

PEG Ratio

-0.01

Profit Margin

Operating Margin

Return on Assets (ttm)

-46.7

Return on Equity (ttm)

-88.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.431

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.05

Levered Free Cash Flow (M)

-11.53

FoxReading.com

Valuation

P/E

-0.97

P/E Growth Ratio

-0.03

P/BV

1.26

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-06-03

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.